Page last updated: 2024-11-04

sarpogrelate and Coronary Stenosis

sarpogrelate has been researched along with Coronary Stenosis in 1 studies

sarpogrelate: structure given in first source

Coronary Stenosis: Narrowing or constriction of a coronary artery.

Research Excerpts

ExcerptRelevanceReference
"8 years with 10-75% coronary artery stenosis, as assessed by coronary computed tomography angiography, were randomly assigned to sarpogrelate 300 mg/day plus aspirin 100 mg/day (SPG + ASA group) or aspirin 100 mg/day alone (ASA group) for 6 months."5.24Effect of sarpogrelate, a selective 5-HT ( Chun, EJ; Han, SJ; Hur, JH; Jang, HC; Kang, DK; Kim, HJ; Kim, KM; Lee, DH; Lee, JE; Lim, S; Min, SH; Oh, TJ, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, DH1
Chun, EJ1
Hur, JH1
Min, SH1
Lee, JE1
Oh, TJ1
Kim, KM1
Jang, HC1
Han, SJ1
Kang, DK1
Kim, HJ1
Lim, S1

Trials

1 trial available for sarpogrelate and Coronary Stenosis

ArticleYear
Effect of sarpogrelate, a selective 5-HT
    Atherosclerosis, 2017, Volume: 257

    Topics: Adult; Aged; Ankle Brachial Index; Anti-Inflammatory Agents; Aspirin; Biomarkers; Computed Tomograph

2017